Value of bronchoalveolar lavage before haematopoietic stem cell transplantation for primary immunodeficiency or autoimmune diseases

Bone Marrow Transplantation

Volumn 40, Issue 6, 2007, Pages 529-533

  Slatter, M A ^a   Rogerson, E J ^a   Taylor, C E ^b   Galloway, A ^c   Clark, J E ^a   Flood, T J ^a   Abinun, M ^a   Cant, A J ^a   Gennery, A R ^a  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^c ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFTAZIDIME; CEFUROXIME; COTRIMOXAZOLE; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; ITRACONAZOLE; MEROPENEM; OSELTAMIVIR; RIBAVIRIN;

ANTIMICROBIAL THERAPY; ARTICLE; AUTOIMMUNE DISEASE; BRONCHOSCOPY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMBINED IMMUNODEFICIENCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LUNG DISEASE; LUNG INFECTION; LUNG LAVAGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADOLESCENT; ANESTHESIA, GENERAL; AUTOIMMUNE DISEASES; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; CHILD, PRESCHOOL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; PNEUMOCYSTIS JIROVECII; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCYSTIS; PROGNOSIS; PROSPECTIVE STUDIES; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 34548530559     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705776     Document Type: Article

References (10)

1. Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J, et al, European Group for Blood and Marrow Transplantation; European Society for Immunodeficiency. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: Report of the European experience 1968-99. Lancet 2003; 361: 553-560.
2. De Kleer IM, Brinkman DM, Ferster A, Abinun M, Quartier P, Van Der Net J et al. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: Analysis of clinical effects, mortality, and transplant related morbidity. Ann Rheum Dis 2004; 63: 1318-1326.
3. Berrington JE, Flood TJ, Abinun M, Galloway A, Cant AJ. Unsuspected Pneumocystis carinii pneumonia at presentation of severe primary immunodeficiency. Arch Dis Child 2000; 82: 144-147.
4. Kroe DM, Kirsch CM, Jensen WA. Diagnostic strategies for Pneumocystis carinii pneumonia. Semin Respir Infect 1997; 12: 70-78.
5. Whittle AT, Davis M, Johnson PR, Leonard RC, Greening AP. The safety and usefulness of routine bronchoscopy before stem cell transplantation and during neutropenia. Bone Marrow Transplant 1999; 24: 63-67.
6. Efrati O, Gonik U, Bielorai B, Modan-Moses D, Neumann Y, Szeinberg A et al. Fiberoptic bronchoscopy and bronchoalveolar lavage for the evaluation of pulmonary disease in children with primary immunodeficiency and cancer. Pediatr Blood Cancer 2006; 48: 324-329.
7. Park JR, Fogarty S, Brogan TV. Clinical utility of bronchoalveolar lavage in pediatric cancer patients. Med Pediatr Oncol 2002; 39 175-180.
8. Vega-Briceno LE, Holmgren NL, Bertrand P, Rodriguez JI, Barriga F, Contreras I et al. Utility of bronchoalveolar lavage in immunocompromised children: Diagnostic yield and complications. Arch Bronconeumol 2004; 40: 570-574.
9. Bissinger AL, Einsele H, Hamprecht K, Schumacher U, Kandolf R, Loeffler J et al. Infectious pulmonary complications after stem cell transplantation or chemotherapy: Diagnostic yield of bronchoalveolar lavage. Diagn Microbiol Infect Dis 2005; 52: 275-280.
10. Hohenthal U, Itala M, Salonen J, Sipila J, Rantakokko-Jalava K, Meurman O et al. Bronchoalveolar lavage in immunocompromised patients with haematological malignancy - value of new microbiological methods. Eur J Haematol 2005; 74: 203-211.